PRMT9 and neoplasm: In tumor tissue samples, knockdown of PRMT9 decreased the levels of RAS, pMek1/2, Ki67, and pErk1/2 proteins (Figure 6C), while caspase‐3 levels were increased by knockdown of PRMT9 (Figure 6D).